Robot-Enhanced Stroke Therapy Optimizes Rehabilitation (RESTORE)
Launched by UNIVERSITY OF CALGARY · Dec 16, 2019
Trial Information
Current as of July 04, 2025
Unknown status
Keywords
ClinConnect Summary
Medically stable stroke subjects will be recruited in the first few days following their stroke. All participants will complete clinical and robotic assessments of neurologic function at 7 time points. Therapy will occur daily (Monday through Friday) for 20 days.
Study participants will be randomly assigned to 1) start robot therapy early or late after stroke and 2)receive one or two hours of robot therapy per treatment day for four weeks, or 3) control group that will receive the current standard of care.
The participant's chart will be reviewed for information about their stroke and rel...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Recent first stroke (ischemic or hemorrhagic)
- • Upper extremity Fugl-Meyer score 15-45
- • Modified Ashworth score of shoulder/elbow less than or equal to 2
- • Able to follow task instructions
- • Visual acuity better than 20/50 in both eyes
- • Able to give consent
- • Able to commit to follow-up
- Exclusion Criteria:
- • Prior stroke or significant neurologic problem (e.g. Multiple Sclerosis)
- • Pre-existing musculoskeletal injury that will interfere with active therapy
- • Pre-Stroke Modified Rankin Score \> 2
- • Clinical evidence of Unilateral Spatial Neglect on the Behavioural Inattention Test (BIT)
- • Enrollment in a concurrent clinical intervention trial
- • Major co-morbid or concurrent illness such that improvement is unlikely or completion of the protocol as specified is unlikely
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Sean Dukelow, MD, PhD
Principal Investigator
University of Calgary
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials